Type 2 diabetes melitus. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: randomized clinical trial with control group with oral 30 mg glutazone once a day for 3 month in intrvention group. Intervention 2: For control group no drug will be administered.
Treatment - Drugs
randomized clinical trial with control group with oral 30 mg glutazone once a day for 3 month in intrvention group
For control group no drug will be administered.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with the age between 35 and 75 years on anti-diabetic drugs; without any history of thiazolidindione use Exclusion criteria: patients who do not use anti diabetic drugs regularly or don’t like to continue the study; patients with cirrhosis and advance congestive heart failure
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: 2012 novamber to march2013. Method of measurement: labratory. | — |
Primary
| Measure | Time frame |
|---|---|
| Lipid profile. Timepoint: Before and after treatment. Method of measurement: laboratory testing.;Liver enzyme. Timepoint: november 2012 to march 2013. Method of measurement: labratory.;Weight. Timepoint: november 2012 to march 2013. Method of measurement: balance. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaser Aghamohammadzadeh
Tabriz University of Medical Sciences
Outcome results
None listed